Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Long Term Debt 2008–2025
Regeneron Pharmaceuticals, Inc. annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Regeneron Pharmaceuticals, Inc. long term debt as of December 31, 2025: 1.99B, a 0.08% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. long term debt for 2025 were 1.99B, a 0.08% increase from 2024.
- Regeneron Pharmaceuticals, Inc. long term debt for 2024 were 1.98B, a 0.08% increase from 2023.
- Regeneron Pharmaceuticals, Inc. long term debt for 2023 were 1.98B, a 0.08% increase from 2022.
- Regeneron Pharmaceuticals, Inc. long term debt for 2022 were 1.98B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Regeneron Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $1,986 |
| 2024 | $1,984 |
| 2023 | $1,983 |
| 2022 | $1,981 |
| 2021 | $1,980 |
| 2020 | $1,979 |
Regeneron Pharmaceuticals Inc. Long Term Debt — FAQ
Regeneron Pharmaceuticals Inc. (REGN) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's long term debt history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.